We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
+11.42%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$741M
AUM Growth
+$59.6M
Cap. Flow
+$1.93M
Cap. Flow %
0.26%
Top 10 Hldgs %
34.87%
Holding
94
New
6
Increased
31
Reduced
35
Closed
3

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$29.1M
2
GOOGM
Alphabet Inc Depositary Shares Series A Preferred Stock
GOOGM
+$23.6M
3
CMCSA icon
Comcast
CMCSA
+$7.96M
4
CEG icon
Constellation Energy
CEG
+$4.43M
5
KKR.PRD
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
+$3.87M

Top Sells

Rank Stock Value
1
HPE.PRC
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
+$18.2M
2
MSFT icon
Microsoft
MSFT
+$16.8M
3
TXN icon
Texas Instruments
TXN
+$15.3M
4
JPM icon
JPMorgan Chase
JPM
+$11.1M
5
MS icon
Morgan Stanley
MS
+$5.63M

Sector Composition

Rank Sector Weight
1 Technology 22.5%
2 Healthcare 18.63%
3 Financials 12.3%
4 Energy 8.61%
5 Communication Services 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.59T
$13.5M 1.82%
36,160
-41,572
-53% -$16.8M
CASY icon
27
Casey's General Stores
CASY
$30.9B
$13.3M 1.8%
16,784
-337
-2% -$272K
TSM icon
28
TSMC
TSM
$2.17T
$12.6M 1.69%
26,309
-801
-3% -$325K
KLAC icon
29
KLA
KLAC
$240B
$11.1M 1.5%
36,890
-7,160
-16% -$1.42M
APH icon
30
Amphenol
APH
$194B
$10.4M 1.41%
59,235
-3,900
-6% -$562K
TW icon
31
Tradeweb Markets
TW
$22.6B
$7.57M 1.02%
75,987
-62
-0.1% -$6.73K
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$139B
$7.56M 1.02%
15,215
-171
-1% -$75.8K
V icon
33
Visa
V
$693B
$7.55M 1.02%
22,017
+2,217
+11% +$712K
AJG icon
34
Arthur J. Gallagher & Co
AJG
$67.6B
$6.03M 0.81%
26,276
-2,759
-10% -$586K
RBC icon
35
RBC Bearings
RBC
$16B
$5.87M 0.79%
9,112
+32
+0.4% +$19K
ORLY icon
36
O'Reilly Automotive
ORLY
$72.1B
$5.6M 0.76%
60,821
-1,551
-2% -$141K
MPWR icon
37
Monolithic Power Systems
MPWR
$64.7B
$5.14M 0.69%
3,715
+8
+0.2% +$12K
NOW icon
38
ServiceNow
NOW
$133B
$5.12M 0.69%
51,543
-3,311
-6% -$328K
KRYS icon
39
Krystal Biotech
KRYS
$10.3B
$4.52M 0.61%
12,156
+124
+1% +$37K
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$12.9B
$4.45M 0.6%
77,705
-465
-0.6% -$25.5K
VEEV icon
41
Veeva Systems
VEEV
$40.3B
$4.37M 0.59%
24,625
+867
+4% +$143K
VRSK icon
42
Verisk Analytics
VRSK
$24.4B
$4.36M 0.59%
24,309
-78
-0.3% -$13.7K
SHW icon
43
Sherwin-Williams
SHW
$84.1B
$4.19M 0.57%
12,175
+562
+5% +$180K
GE icon
44
GE Aerospace
GE
$361B
$4.11M 0.55%
10,999
+467
+4% +$146K
AXSM icon
45
Axsome Therapeutics
AXSM
$10.9B
$3.65M 0.49%
14,928
+154
+1% +$33.4K
FN icon
46
Fabrinet
FN
$15.6B
$3.37M 0.45%
5,994
-1,077
-15% -$694K
ENTG icon
47
Entegris
ENTG
$22B
$3.24M 0.44%
18,001
+60
+0.3% +$8.65K
HALO icon
48
Halozyme
HALO
$12.3B
$3.03M 0.41%
38,703
+524
+1% +$35.7K
RYAN icon
49
Ryan Specialty Holdings
RYAN
$11.1B
$2.94M 0.4%
77,911
+9,865
+14% +$335K
SNDX icon
50
Syndax Pharmaceuticals
SNDX
$1.75B
$2.93M 0.39%
133,835
+28,967
+28% +$602K
1
2
3 4

Similar funds

LGA
Lebenthal Global Advisors Hauppauge, New York $741M AUM 22.36% 1-Year Est. Return
SIC
SFE Investment Counsel Los Angeles, California $742M AUM 39.38% 1-Year Est. Return
CPC
Consolidated Planning Corp Atlanta, Georgia $742M AUM 25.54% 1-Year Est. Return
NC
Northcape Capital Sydney, Australia $742M AUM 2.34% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $742M AUM 17.39% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $742M AUM 23.98% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $741M AUM 78.82% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $740M AUM 69.74% 1-Year Est. Return

Robert Torray's Q2 2026 Portfolio in Review

As of Q2 2026, Robert Torray held 94 positions worth $741M, up 8.7% from $682M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Robert Torray's Q2 2026 filing shows 6 new, 31 increased, 35 reduced and 3 closed positions. Its largest new stake was Accenture: 167,690 shares worth $20.9M. The largest sale was Hewlett Packard Enterprise 7.625% Series C Preferred Stock, an estimated $18.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Robert Torray's largest Q2 2026 buy was Accenture: 167,690 shares worth $20.9M.
  • Robert Torray added most to Comcast in Q2 2026, an estimated $7.96M increase.
  • Robert Torray's biggest Q2 2026 reduction was Hewlett Packard Enterprise 7.625% Series C Preferred Stock, cutting an estimated $18.2M.
  • Robert Torray fully exited Huron Consulting in Q2 2026, selling an estimated $1.99M.
  • Robert Torray's ten largest holdings make up 35% of its $741M portfolio in Q2 2026.
  • Robert Torray opened 6 new positions and closed 3 in Q2 2026.
  • Robert Torray's portfolio value rose 8.7% quarter-over-quarter to $741M.

Based on Torray Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.